Shin Poong Pharm.Co.,Ltd.

KSE 019170.KS

Shin Poong Pharm.Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2023: USD 46.43 M

Shin Poong Pharm.Co.,Ltd. Cash and Short-Term Investments is USD 46.43 M for the year ending December 31, 2023, a 5.12% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Shin Poong Pharm.Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2022 was USD 44.17 M, a -43.07% change year over year.
Shin Poong Pharm.Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2021 was USD 77.59 M, a -55.66% change year over year.
Shin Poong Pharm.Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2020 was USD 175.01 M, a 206.86% change year over year.
Shin Poong Pharm.Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2019 was USD 57.03 M, a -4.20% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

KSE: 019170.KS

Shin Poong Pharm.Co.,Ltd.

CEO	Mr. Jei-Man Ryu
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	161, Yeoksam-ro
Employees	828
Sector	Healthcare
Industries Pharmaceuticals Automotive Parts Cleaning Supplies Composite Materials Drugstores & Retail Pharmacies Eyewear Personal Care Plastics

Description

Shin Poong Pharm.Co.,Ltd. manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products. It also provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; and over the counter products. The company also exports its products to approximately 50 countries. Shin Poong Pharm.Co.,Ltd. was founded in 1962 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years